Anna Wynn serves as the President of IDEX MPT at IDEX Corporation, leading a global platform encompassing multiple businesses that produce essential equipment for the pharmaceutical, food, and vaccine industries. Wynn's previous roles include Senior Director of Clinical Product Solutions and General Manager of New Born Screening Business at Waters Corporation, along with Business Director for Drug Discovery & Advanced Cell Culture at Corning Incorporated, where capabilities in organic growth and strategic leadership were demonstrated. Additionally, Wynn held significant positions at Instron and Tissue Growth Technologies & Medical Devices Testing Services, managing product development and business operations. Anna Wynn earned an MBA from the University of Minnesota's Carlson School of Management, a BS in Biology from the University of Minnesota, and a MS in Molecular Biology from the University of North Carolina Wilmington.
This person is not in any teams
This person is not in any offices